Biomaterial Database

[Determination of nevadensin in specimens and its pharmacokinetic (author's transl)]. 1981

G Z Han, and C Y Su, and Y Zhang

UI	MeSH Term	Description	Entries
D007408	Intestinal Absorption	Uptake of substances through the lining of the INTESTINES.	Absorption, Intestinal
D007700	Kinetics	The rate dynamics in chemical or physical systems.
D008099	Liver	A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances.	Livers
D008297	Male		Males
D004285	Dogs	The domestic dog, Canis familiaris, comprising about 400 breeds, of the carnivore family CANIDAE. They are worldwide in distribution and live in association with people. (Walker's Mammals of the World, 5th ed, p1065)	Canis familiaris,Dog
D005260	Female		Females
D005419	Flavonoids	A group of phenyl benzopyrans named for having structures like FLAVONES.	2-Phenyl-Benzopyran,2-Phenyl-Chromene,Bioflavonoid,Bioflavonoids,Flavonoid,2-Phenyl-Benzopyrans,2-Phenyl-Chromenes,2 Phenyl Benzopyran,2 Phenyl Benzopyrans,2 Phenyl Chromene,2 Phenyl Chromenes
D006207	Half-Life	The time it takes for a substance (drug, radioactive nuclide, or other) to lose half of its pharmacologic, physiologic, or radiologic activity.	Halflife,Half Life,Half-Lifes,Halflifes
D000818	Animals	Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA.	Animal,Metazoa,Animalia
D000995	Antitubercular Agents	Drugs used in the treatment of tuberculosis. They are divided into two main classes: "first-line" agents, those with the greatest efficacy and acceptable degrees of toxicity used successfully in the great majority of cases; and "second-line" drugs used in drug-resistant cases or those in which some other patient-related condition has compromised the effectiveness of primary therapy.	Anti-Tuberculosis Agent,Anti-Tuberculosis Agents,Anti-Tuberculosis Drug,Anti-Tuberculosis Drugs,Antitubercular Agent,Antitubercular Drug,Tuberculostatic Agent,Tuberculostatic Agents,Antitubercular Drugs,Agent, Anti-Tuberculosis,Agent, Antitubercular,Agent, Tuberculostatic,Anti Tuberculosis Agent,Anti Tuberculosis Agents,Anti Tuberculosis Drug,Anti Tuberculosis Drugs,Drug, Anti-Tuberculosis,Drug, Antitubercular

Related Publications

G Z Han, and C Y Su, and Y Zhang

LC-MS/MS determination of nevadensin in rat plasma and its application in pharmacokinetic studies.

February 2013, Journal of pharmaceutical and biomedical analysis,

G Z Han, and C Y Su, and Y Zhang

[Synthesis of Nevadensin analogues and their anti-tuberculosis activity (author's transl)].

October 1981, Yao xue xue bao = Acta pharmaceutica Sinica,

G Z Han, and C Y Su, and Y Zhang

[Theophylline: pharmacokinetic parameters and determination of an efficient individual dosage (author's transl)].

January 1981, Bulletin europeen de physiopathologie respiratoire,

G Z Han, and C Y Su, and Y Zhang

[Cortical blindness and its electrophysiological determination (author's transl)].

January 1974, Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie. Albrecht von Graefe's archive for clinical and experimental ophthalmology,

G Z Han, and C Y Su, and Y Zhang

[Enzymatic determination of cholesterol and its clinical application (author's transl)].

May 1977, Rinsho byori. The Japanese journal of clinical pathology,

G Z Han, and C Y Su, and Y Zhang

[Current determination of pituitary hormones and its problem (author's transl)].

August 1979, Rinsho byori. The Japanese journal of clinical pathology,

G Z Han, and C Y Su, and Y Zhang

[Description of the pharmacokinetic behaviour of Etozolin and its main metabolite (author's transl)].

January 1977, Arzneimittel-Forschung,

G Z Han, and C Y Su, and Y Zhang

[Pharmacokinetic profil of ketoprofen (author's transl)].

January 1978, Annales pharmaceutiques francaises,